These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 24463822)
1. HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy. Beharry AW; Sandesara PB; Roberts BM; Ferreira LF; Senf SM; Judge AR J Cell Sci; 2014 Apr; 127(Pt 7):1441-53. PubMed ID: 24463822 [TBL] [Abstract][Full Text] [Related]
2. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Senf SM; Dodd SL; Judge AR Am J Physiol Cell Physiol; 2010 Jan; 298(1):C38-45. PubMed ID: 19864323 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. Reed SA; Sandesara PB; Senf SM; Judge AR FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy. Reed SA; Senf SM; Cornwell EW; Kandarian SC; Judge AR Biochem Biophys Res Commun; 2011 Feb; 405(3):491-6. PubMed ID: 21256828 [TBL] [Abstract][Full Text] [Related]
5. Posttranslational modifications control FoxO3 activity during denervation. Bertaggia E; Coletto L; Sandri M Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330 [TBL] [Abstract][Full Text] [Related]
6. p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. Senf SM; Sandesara PB; Reed SA; Judge AR Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1490-501. PubMed ID: 21389279 [TBL] [Abstract][Full Text] [Related]
7. Class I HDAC inhibitors attenuate dexamethasone-induced muscle atrophy via increased protein kinase C (PKC) delta phosphorylation. Habibian JS; Bolino M; Qian A; Woolsey R; Quilici D; Petereit J; Ferguson BS Cell Signal; 2023 Oct; 110():110815. PubMed ID: 37478958 [TBL] [Abstract][Full Text] [Related]
8. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499 [TBL] [Abstract][Full Text] [Related]
9. Hsp27 inhibits IKKbeta-induced NF-kappaB activity and skeletal muscle atrophy. Dodd SL; Hain B; Senf SM; Judge AR FASEB J; 2009 Oct; 23(10):3415-23. PubMed ID: 19528257 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy. Ratti F; Ramond F; Moncollin V; Simonet T; Milan G; Méjat A; Thomas JL; Streichenberger N; Gilquin B; Matthias P; Khochbin S; Sandri M; Schaeffer L J Biol Chem; 2015 Feb; 290(7):4215-24. PubMed ID: 25516595 [TBL] [Abstract][Full Text] [Related]
11. FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension. Brocca L; Toniolo L; Reggiani C; Bottinelli R; Sandri M; Pellegrino MA J Physiol; 2017 Feb; 595(4):1143-1158. PubMed ID: 27767211 [TBL] [Abstract][Full Text] [Related]
13. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. Lee D; Goldberg AL J Biol Chem; 2013 Oct; 288(42):30515-30526. PubMed ID: 24003218 [TBL] [Abstract][Full Text] [Related]
14. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome. Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of HDAC and HAT genes in atrophying skeletal muscle. Beharry AW; Judge AR Muscle Nerve; 2015 Dec; 52(6):1098-101. PubMed ID: 26372908 [TBL] [Abstract][Full Text] [Related]
16. Trichostatin A inhibits skeletal muscle atrophy induced by cigarette smoke exposure in mice. Ding J; Li F; Cong Y; Miao J; Wu D; Liu B; Wang L Life Sci; 2019 Oct; 235():116800. PubMed ID: 31472151 [TBL] [Abstract][Full Text] [Related]
17. FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy. O'Neill BT; Bhardwaj G; Penniman CM; Krumpoch MT; Suarez Beltran PA; Klaus K; Poro K; Li M; Pan H; Dreyfuss JM; Nair KS; Kahn CR Diabetes; 2019 Mar; 68(3):556-570. PubMed ID: 30523026 [TBL] [Abstract][Full Text] [Related]
18. NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy. Wu CL; Cornwell EW; Jackman RW; Kandarian SC Am J Physiol Cell Physiol; 2014 Apr; 306(8):C762-7. PubMed ID: 24553183 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia. Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728 [TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis. Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]